Risk factors for Parkinson's disease include:
July 07, 2015
- Age. Young adults rarely experience Parkinson's disease. It ordinarily begins in middle or late life, and the risk increases with age. People usually develop the disease around age 60 or older.
- Heredity. Having a close relative with Parkinson's disease increases the chances that you'll develop the disease. However, your risks are still small unless you have many relatives in your family with Parkinson's disease.
- Sex. Men are more likely to develop Parkinson's disease than are women.
- Exposure to toxins. Ongoing exposure to herbicides and pesticides may put you at a slightly increased risk of Parkinson's disease.
- Longo DL, et al. Parkinson's disease and other movement disorders. In: Harrison's Principles of Internal Medicine. 18th ed. New York, N.Y.: The McGraw-Hill Companies; 2012. http://accessmedicine.com. Accessed April 6, 2015.
- Parkinson's disease: Hope through research. National Institute of Neurological Disorders and Stroke. http://www.ninds.nih.gov/disorders/parkinsons_disease/detail_parkinsons_disease.htm. Accessed April 6. 2015.
- Ferri FF. Parkinson's disease. In: Ferri's Clinical Advisor 2015: 5 Books in 1. Philadelphia, Pa.: Mosby Elsevier; 2015. https://www.clinicalkey.com. Accessed April 6, 2015.
- Chou KL. Diagnosis of Parkinson disease. http://www.uptodate.com/home. Accessed April 6. 2015.
- Tarsy D. Pharmacologic treatment of Parkinson disease. http://www.uptodate.com/home. Accessed April 6. 2015.
- Adler CH, et al. Submandibular gland needle biopsy for the diagnosis of Parkinson disease. Neurology. 2014;82:858.
- Bousquet M, et al. Impact of omega-3 fatty acids in Parkinson's disease. Ageing Research Reviews. 2011;10:453.
- Parkinson's disease: Fitness counts. National Parkinson Foundation. http://www.parkinson.org/Search-Pages/Search.aspx?pKeywords=fitness. Accessed April 9, 2015.
- Parkinson's disease. Natural Medicines Comprehensive Database. http://www.naturaldatabase.com. Accessed April 6, 2015.
- Tarsy D. Nonpharmacologic management of Parkinson disease. http://www.uptodate.com/home/. Accessed April 6, 2015.
- Complementary therapies and Parkinson's. Parkinson's Disease Society of the United Kingdom. http://www.parkinsons.org.uk/content/complementary-therapies-and-parkinsons-booklet. Accessed April 9, 2015.
- Jankovic J. Etiology and pathogenesis of Parkinson disease. http://www.uptodate.com/home. Accessed April 6, 2015.
- Riggs EA. Decision Support System. Mayo Clinic, Rochester, Minn. April 16, 2015.
- Abbvie announces U.S. approval of duopa (carbidopa and levodopa) enteral suspension for the treatment of motor fluctuations in patients with advanced Parkinson's disease. http://abbvie.mediaroom.com/2015-01-12-AbbVie-Announces-U-S-FDA-Approval-of-DUOPA-carbidopa-and-levodopa-Enteral-Suspension-for-the-Treatment-of-Motor-Fluctuations-in-Patients-with-Advanced-Parkinsons-Disease. Accessed April 20, 2015.
- Bower JH (expert opinion). Mayo Clinic, Rochester, Minn. April 20, 2015.